NASDAQ: TCDA - Tricida, Inc.

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Tricida, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Tricida, Inc.

Фармацевтическая компания Tricida, Inc. сосредоточена на разработке и коммерциализации своего препарата-кандидата TRC101, не абсорбируемого перорального полимера, предназначенного для потенциального лечения метаболического ацидоза у пациентов с хронической болезнью почек (ХБП). Компания завершила фазу 3, двойное слепое плацебо-контролируемое исследование TRC101 у пациентов с ХБП и метаболическим ацидозом. Компания Tricida, Inc. была основана в 2013 году со штаб-квартирой в Южном Сан-Франциско, штат Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2018-06-28
ISIN US89610F1012
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.tricida.com
Цена ао 0.0141
Change price per day: 0% (0.0141)
Change price per week: 0% (0.0141)
Change price per month: 0% (0.0141)
Change price per 3 month: 0% (0.0141)
Change price per half year: 0% (0.0141)
Change price per year: 0% (0.0141)
Change price per 3 year: -99.85% (9.23)
Change price per 5 year: -99.94% (25.35)
Change price per year to date: 0% (0.0141)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV -0.006 0
P/E 0 0
EV/EBITDA -1.54 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % -102.07 0
ROE, % 197.1 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -1.68 10
Total: 9.2

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 20.94 4
Yield EPS, % -50.22 0
Total: 2.2
More

Institutions Volume Share, %
Orbimed Advisors LLC. 10280947 18.47
VR Adviser, LLC 9050064 16.26
Blackrock Inc. 3698400 6.64
Frazier Life Sciences Management, L.P. 2549671 4.58
Commodore Capital, LP 1975403 3.55
Vanguard Group, Inc. (The) 1661860 2.99
Lion Point Capital, LP 1367597 2.46
Baker Brothers Advisors, LLC 1320290 2.37
Stonehill Capital Management LLC 1198443 2.15
Deep Track Capital, LP 1177680 2.12



Head Job title Payment Year of birth
Mr. Geoffrey M. Parker COO, CFO & Exec. VP 656.28k 1964 (61 year)
Mr. Robert L. McKague J.D. Exec. VP, Company Sec., Gen. Counsel & Chief Compliance Officer 570.51k
Dr. Dawn Parsell Ph.D. Exec. VP of Clinical Devel. 649.17k 1962 (63 years)
Ms. Annie Yoshiyama VP of Fin. & Chief Accounting Officer N/A 1983 (42 years)
Jackie Cossmon VP of Investor Relations & Communications N/A
Mr. Edward J. Hejlek Esq., J.D. Exec. VP of Intellectual Property N/A 1956 (69 years)
Dr. Gerrit Klaerner Ph.D. Founder, Pres, CEO & Exec. Director 992.55k 1972 (53 years)

Address: United States, South San Francisco, 7000 Shoreline Court - open in Google maps, open in Yandex maps
Website: http://www.tricida.com